Pinnacle Financial Group, Inc.’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ORMP
GIA
BCM
Pinnacle Financial Group, Inc.'s ORMP Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 984 shares worth $4.6K. The stake represents ﹤0.01% of the portfolio and ranks #1806 among its holdings.
90 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.
- Pinnacle Financial Group, Inc. held 984 shares of Oramed Pharmaceuticals worth $4.6K as of Q3 2026.
- Oramed Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Oramed Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #1806 holding.
- 90 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.